FDA Preps New Guidance on Generative AI Devices
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- FDA released a new discussion paper focused on generative AI medical devices, the first formal public step the agency has taken toward writing guidance for that product category.
- Epic's annual User Group Meeting produced announcements that STAT plans to recap, including details that were set aside before the publication's summer break.
Why it matters: An FDA discussion paper is the standard precursor to draft guidance, meaning medical-device makers and health systems deploying generative AI tools now have a concrete signal of where regulators are headed—a stake in the ground that didn't exist a week ago.
Ask SkimNews
